{"id":803490,"date":"2026-04-21T12:46:02","date_gmt":"2026-04-21T12:46:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=803490"},"modified":"2026-04-21T12:46:02","modified_gmt":"2026-04-21T12:46:02","slug":"is-chip-still-enough-cuttag-is-emerging-as-a-new-standard-in-epigenetics","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/is-chip-still-enough-cuttag-is-emerging-as-a-new-standard-in-epigenetics_803490.html","title":{"rendered":"Is ChIP Still Enough? CUT&#038;Tag is Emerging as a New Standard in Epigenetics"},"content":{"rendered":"<p style=\"text-align: justify;\">Epigenetic research is entering a stage where chromatin profiling is increasingly defined by high-resolution, low-input technologies rather than traditional workflows.<\/p>\n<p style=\"text-align: justify;\">Understanding gene regulation requires mapping DNA-protein interactions, identifying transcription factor binding sites, and profiling histone modifications. In many diseases&mdash;especially cancer&mdash;biological outcomes are not driven solely by genetic mutations. Epigenetic regulation plays a critical role.<\/p>\n<p style=\"text-align: justify;\">Epigenomic technologies are now widely used across fields such as cancer research, stem cell and developmental biology, immunology, and single-cell genomics.<\/p>\n<p style=\"text-align: justify;\">For more than two decades, researchers have relied on Chromatin Immunoprecipitation sequencing (ChIP-Seq) to study chromatin regulation. However, with the rise of low-input samples, single-cell technologies, and high-resolution epigenomics, traditional ChIP-Seq faces increasing challenges in experimental efficiency, sample requirements, and signal-to-noise ratio.<\/p>\n<p style=\"text-align: justify;\">A new and powerful technique&mdash;Cleavage Under Targets and Tagmentation (CUT&amp;Tag)&mdash;has rapidly gained attention as a more sensitive and efficient approach for chromatin profiling.<\/p>\n<p style=\"text-align: justify;\">How did CUT&amp;Tag rise so quickly? We&rsquo;ll walk through the technological evolution from ChIP-Seq to CUT&amp;Tag.<\/p>\n<p style=\"text-align: justify;\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/vazyme-singapore-website-prod.s3.ap-southeast-1.amazonaws.com\/9d35b0a2ff5a4ba09d255bda43948cdb\" alt=\"Is ChIP Still Enough? CUT&amp;Tag is Emerging as a New Standard in Epigenetics\" width=\"570\" height=\"334\" \/><\/p>\n<p style=\"text-align: justify;\"><em>Fig.1 From ChIP-Seq to CUT&amp;Tag: The evolution of chromatin profiling[1].<\/em><\/p>\n<p style=\"text-align: justify;\">a. ChIP-Seq&mdash;the classic method: Genome-wide mapping of protein-DNA interactions; requires crosslinking, chromatin fragmentation, and relatively high cell input.<\/p>\n<p style=\"text-align: justify;\">b. CUT&amp;RUN&mdash;lower background: In situ cleavage using antibody-guided MNase, reducing background and improving signal specificity.<\/p>\n<p style=\"text-align: justify;\">c. CUT&amp;Tag&mdash;higher sensitivity: Targeted fragmentation with pAG-Tn5 enables high-sensitivity chromatin profiling with low input and a simplified workflow.<\/p>\n<p style=\"text-align: justify;\"><strong>ChIP-<\/strong><strong>S<\/strong><strong>eq: <\/strong><strong>T<\/strong><strong>he classic approach<\/strong><\/p>\n<p style=\"text-align: justify;\">ChIP-Seq enriches DNA fragments bound by specific proteins through immunoprecipitation, followed by high-throughput sequencing to identify binding sites across the genome. A typical workflow includes crosslinking, chromatin fragmentation, antibody immunoprecipitation, DNA purification, and library preparation[2].<\/p>\n<p style=\"text-align: justify;\">Despite its widespread use, ChIP-Seq has several limitations:<\/p>\n<p style=\"text-align: justify;\">&bull; Long experimental time (typically 4 &#8211; 7 days)<\/p>\n<p style=\"text-align: justify;\">&bull; High sample input requirements<\/p>\n<p style=\"text-align: justify;\">&bull; Crosslinking variability that may introduce false positives or negatives<\/p>\n<p style=\"text-align: justify;\">&bull; Challenging optimization of chromatin fragmentation<\/p>\n<p style=\"text-align: justify;\">&bull; High background noise in sequencing data<\/p>\n<p style=\"text-align: justify;\">As epigenetic research moves toward lower input, higher resolution, and more streamlined workflows, new technologies such as CUT&amp;Tag have emerged to address these challenges.<\/p>\n<p style=\"text-align: justify;\"><strong>CUT&amp;Tag: <\/strong><strong>A<\/strong><strong> next-generation chromatin profiling method<\/strong><\/p>\n<p style=\"text-align: justify;\">CUT&amp;Tag uses a Protein A\/G-Tn5 transposase to bind antibodies and directly tag and cleave DNA at target sites <em>in situ<\/em>. After PCR amplification, sequencing-ready libraries can be generated directly[3].<\/p>\n<p style=\"text-align: justify;\">Compared with ChIP-Seq, CUT&amp;Tag offers several advantages:<\/p>\n<p style=\"text-align: justify;\">&bull; No crosslinking or sonication required<\/p>\n<p style=\"text-align: justify;\">&bull; Much lower background noise<\/p>\n<p style=\"text-align: justify;\">&bull; Higher signal-to-noise ratio<\/p>\n<p style=\"text-align: justify;\">&bull; Compatible with very low cell input (hundreds to thousands of cells, even ~10 cells)<\/p>\n<p style=\"text-align: justify;\">&bull; Fast workflow &mdash; completed within one day<\/p>\n<p style=\"text-align: justify;\"><img decoding=\"async\" src=\"https:\/\/vazyme-singapore-website-prod.s3.ap-southeast-1.amazonaws.com\/6de1b639a6e746cf82f8c66e0c9e8770\" alt=\"Is ChIP Still Enough? CUT&amp;Tag is Emerging as a New Standard in Epigenetics\" \/><\/p>\n<p style=\"text-align: justify;\"><em>Fig. 2 CUT&amp;Tag reveals cleaner chromatin profiles with a markedly higher signal-to-noise ratio.<\/em><\/p>\n<p style=\"text-align: justify;\">With ultra-low input requirements, efficient library preparation, and superior sequencing efficiency, CUT&amp;Tag is particularly well suited for rare samples and multi-omic studies, enabling high-resolution exploration of epigenetic regulation.<\/p>\n<p style=\"text-align: justify;\"><img decoding=\"async\" src=\"https:\/\/vazyme-singapore-website-prod.s3.ap-southeast-1.amazonaws.com\/6ba8a2e89dc4423888985e25fc4df9f6\" alt=\"Is ChIP Still Enough? CUT&amp;Tag is Emerging as a New Standard in Epigenetics\" \/><\/p>\n<p style=\"text-align: justify;\"><em>Fig. 3 Multi-omic profiling reveals resistance to KRAS inhibition in LKB1-mutant lung cancer.<\/em><\/p>\n<p style=\"text-align: justify;\">As research questions become more complex, traditional ChIP-Seq often struggles to deliver optimal data quality. CUT&amp;Tag, with its low input requirement, high sensitivity, and streamlined workflow, is rapidly emerging as a powerful new approach for epigenetic profiling.<\/p>\n<p style=\"text-align: justify;\">If you are studying transcription factor binding, histone modifications, or epigenomics with limited input material, CUT&amp;Tag offers an efficient and reliable solution.<\/p>\n<p style=\"text-align: justify;\">1. Kaya-Okur, H. S., Janssens, D. H., Henikoff, J. G., Ahmad, K. &amp; Henikoff, S. Efficient low-cost chromatin profiling with CUT&amp;Tag. Nature Protocols 15, 3264&ndash;3283 (2020).<\/p>\n<p style=\"text-align: justify;\">2. Johnson, D. S., Mortazavi, A., Myers, R. M. &amp; Wold, B. Genome-wide mapping of in vivo protein&ndash;DNA interactions. Science 316, 1497&ndash;1502 (2007).<\/p>\n<p style=\"text-align: justify;\">3. Kaya-Okur, H. S. et al. CUT&amp;Tag for efficient epigenomic profiling of small samples and single cells. Nature Communications 10, 1930 (2019).<\/p>\n<p style=\"text-align: justify;\">4. Li, X. et al. Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1-mutant lung cancer. Nature 605, 764&ndash;773 (2022).<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/vazymebiotech.com_121117.html\" rel=\"nofollow\">Vazyme<\/a><br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=is-chip-still-enough-cuttag-is-emerging-as-a-new-standard-in-epigenetics\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Country:<\/strong> China<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.vazymebiotech.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.vazymebiotech.com\/<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=is-chip-still-enough-cuttag-is-emerging-as-a-new-standard-in-epigenetics\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Epigenetic research is entering a stage where chromatin profiling is increasingly defined by high-resolution, low-input technologies rather than traditional workflows. Understanding gene regulation requires mapping DNA-protein interactions, identifying transcription factor binding sites, and profiling histone modifications. In many diseases&mdash;especially cancer&mdash;biological &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/is-chip-still-enough-cuttag-is-emerging-as-a-new-standard-in-epigenetics_803490.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,410,403,404,416],"tags":[],"class_list":["post-803490","post","type-post","status-publish","format-standard","hentry","category-Business","category-Manufacturing-Industry","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/803490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=803490"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/803490\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=803490"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=803490"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=803490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}